In Illinois, researchers discovered how the most deadly pediatric brain tumor, diffuse intrinsic pontine glioma, develops and found a compound that can flip the switch on cancer-promoting genes turning them off so the tumor shrinks. Researchers used biopsied tumor samples from patients to create the lab models and it took less than two years for them to make the discovery. Considering only 5 percent of children with this brain tumor survive, being able to shrink tumors and increase survival rates in animal models is giving major hope for children and their parents. Clinical trials will begin at the Ann & Robert H. Lurie Children’s Hospital of Chicago by the end of the year.
Latest article
Sustainable surgery: Biobased caps debut at Scottish hospital
In Scotland, a hospital is helping to address medical waste by providing staff with biobased caps for the surgical theater. Made from cellulosic fiber,...
UAE expanding greenery with natural latex balloons laden with seeds
In Abu Dhabi, 100,000 natural latex balloons carrying about 100 million seeds were released on New Year’s Eve, with hopes the stunt would help...
Sequinova’s cellulose sequins help fashion stay sparkly
In London, a sustainable sequins start-up has achieved the world’s first fully biodegradable sequins produced at scale.
Founded by Claire Lichfield during the pandemic...